Jiangsu Jibeier Pharmaceutical Co. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 12.19% vs 3.91% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -17.21% vs -5.73% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "226.40",
          "val2": "201.80",
          "chgp": "12.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "50.40",
          "val2": "60.50",
          "chgp": "-16.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.90",
          "val2": "49.40",
          "chgp": "-17.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "222.50%",
          "val2": "281.40%",
          "chgp": "-5.89%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.61% vs 3.88% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 19.18% vs 0.09% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "954.00",
          "val2": "886.50",
          "chgp": "7.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "265.50",
          "val2": "300.30",
          "chgp": "-11.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.20",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "261.00",
          "val2": "219.00",
          "chgp": "19.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "259.00%",
          "val2": "325.80%",
          "chgp": "-6.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

226.40

201.80

12.19%

Operating Profit (PBDIT) excl Other Income

50.40

60.50

-16.69%

Interest

0.00

0.10

-100.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

40.90

49.40

-17.21%

Operating Profit Margin (Excl OI)

222.50%

281.40%

-5.89%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 12.19% vs 3.91% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -17.21% vs -5.73% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

954.00

886.50

7.61%

Operating Profit (PBDIT) excl Other Income

265.50

300.30

-11.59%

Interest

0.40

0.20

100.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

261.00

219.00

19.18%

Operating Profit Margin (Excl OI)

259.00%

325.80%

-6.68%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 7.61% vs 3.88% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 19.18% vs 0.09% in Dec 2024

All Annual Results